Pharma Mar, S.A.
BME:PHM
30.92
+ 0.48€ (1.58%)
30.92
+ 0.48€ (1.58%)
End-of-day quote: 05/02/2024

Pharma Mar financials at a glance

The revenue of Pharma Mar is reported as 0.15815 billion Euro in the fiscal year 2023. The earnings were 0.06 Euro per share in 2023, which was 46.78 lower than 2021. And about 0.01002 billion Euro are reported as free cash flow in the financials of Pharma Mar 2023. Dividends of 0.49 Euro per share were paid to shareholders of Pharma Mar stock BME:PHM in fiscal 2023.

196.34€M
Revenue
2.73€
Earnings Per Share
93.05%
Gross Margin %
29.47€M
Free Cash Flow
Revenue
196.34
Earnings Per Share
2.73
Gross Margin %
93.05
Free Cash Flow
29.47

Financials

Year Year TTM 2022 2021 2020 2019 2018 2017 2016 2015
Rev. Revenue N/A 196.34€M 229.83€M 269.96€M 85.82€M 162.59€M 162.62€M 164.04€M 161.99€M
GM % Gross Margin % 93.67% 93.05% 92.85% 94.92% 93.91% 95.47% 78.01% 75.70% 76.42%
OM Operating Margin 4.65% 21.43% 40.22% 58.02% -20.36% -14.74% -12.30% -10.34% 5.83%
EPS Earnings Per Share 0.77€ 2.73€ 5.13€ 7.49€ -0.48€ -0.84€ -1.39€ -1.32€ 0.36€
Div. Dividends N/A 0.65€ 0.65€ 0.60€ 0.00€ 0.00€ 0.00€ 0.00€ 0.00€
PR % Payout Ratio % 0 23.81% 12.67% 8.01% 0 0 -0.00% -0.00% 0.00%
Sha. Shares N/AM 18.11M 18.01M 18.11M 18.5M 18.44M 18.44M 18.42M 18.44M
OCF Operating Cash Flow N/A 86.85€M 100.77€M 181.27€M -26.14€M -12.36€M -11.66€M -16.40€M 11.10€M
FCF Free Cash Flow N/A 29.47€M 17.87€M 275.94€M -30.05€M -18.72€M -6.12€M -14.51€M 1.88€M
FCFS Free Cash Flow Per Share -1.63€ 1.63€ 0.99€ 15.08€ -1.53€ -1.02€ -0.33€ -0.79€ 0.10€